ArcelorMittal reported a 38% fall in second-quarter earnings on lower steel prices and shipments but said it expected demand to improve in the second half of 2024.
Related Posts
Airbus Sheds $15 Billion in Market Value After Slashing Guidance
Airbus shares in Paris slumped 12% after it lowered its commercial aircraft delivery goal and cut financial targets for the year due to supply-chain hurdles […]
Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.
Fed’s Rate Cut Is Jolting Small Businesses to Spend Again
From restarting expansion plans to boosting marketing, some entrepreneurs are preparing for lower borrowing costs. Others say not so fast.